Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Revenue projections:

Revenue projections for LALPATHLAB
Revenue projections for LALPATHLAB

Dr. Lal PathLabs Limited is projected to see a decline in revenue compared to last year, which could lead to investor caution. A drop in earnings is often viewed as a negative signal for profitability, making it more difficult for the company to maintain investor confidence in its financial health.

Financial Ratios:

currentRatio 0.00000
forwardPE 39.57900
debtToEquity 6.44100
earningsGrowth -0.06600
revenueGrowth 0.10600
grossMargins 0.58503
operatingMargins 0.20794
trailingEps 31.69000
forwardEps 35.43041

Dr. Lal PathLabs Limited's low growth in both earnings and revenue indicates potential profit shrinkage. This downward trend could be a sign of weakening financial health, signaling challenges for the company's future profitability.
LALPATHLAB's positive gross and operating margins reflect strong profitability and operational efficiency. These metrics indicate the company's ability to control costs while maintaining healthy revenue, contributing to its solid financial performance.
With a forward EPS greater than its trailing EPS, LALPATHLAB is expected to see higher profitability this year. The forecasted increase in earnings reflects optimism about the company's financial growth and potential for improved performance over the prior year.

Price projections:

Price projections for LALPATHLAB
Price projections for LALPATHLAB

Over time, LALPATHLAB's price projections have consistently been revised lower. This downward shift suggests analysts are becoming more cautious about the company's future, possibly due to emerging risks or challenges.

Insider Transactions:

Insider Transactions for LALPATHLAB
Insider Transactions for LALPATHLAB


38 transactions were made to sell LALPATHLAB shares, with market price of 2992.748679713199.1 purchases of Dr. Lal PathLabs Limited stock were recorded, with market price of 3308.5 per share.The list of insider transactions is inconclusive, with no evident trend emerging to suggest a notable shift in company behavior or outlook.

Recommendation changes over time:

Recommendations trend for LALPATHLAB
Recommendations trend for LALPATHLAB


Analysts' buy bias for Dr. Lal PathLabs Limited signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to Dr. Lal PathLabs Limited, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.